Hazel Jones
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer, Stress, Anesthesia, and Immune Response 2
- Co-authors
- Jamie Honeychurch (2 shared papers)Eleanor J. Cheadle (1 shared paper)Amy L. Adlard (2 shared papers)Ian J. Stratford (2 shared papers)Grazyna Lipowska‐Bhalla (2 shared papers)Ross Stewart (2 shared papers)Conor McKenna (2 shared papers)Edmund Poon (2 shared papers)
- Journals
- British Journal of Cancer (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United KingdomAustraliaCanada
In The Last Decade
Hazel Jones
7 papers receiving 1.2k citations
Hazel Jones's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 925
- Immunology 409
- Pulmonary and Respiratory Medicine 432
- Otorhinolaryngology 30
- Hepatology 52
Countries citing papers authored by Hazel Jones
This map shows the geographic impact of Hazel Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Jones more than expected).
Fields of papers citing papers by Hazel Jones
This network shows the impact of papers produced by Hazel Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Jones. The network helps show where Hazel Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Hazel Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade Hit paper breakdown → | 2014 | 974 |
| 2 | 2019 | 138 | |
| 3 | 2003 | 75 | |
| 4 | 2004 | 69 | |
| 5 | 2014 | 3 | |
| 6 | 2016 | 2 | |
| 7 | 2016 | 1 |
About Hazel Jones
Hazel Jones is a scholar working on Oncology, Psychiatry and Mental health, Cancer Research, Infectious Diseases and Molecular Biology, having authored 7 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Nanoplatforms for cancer theranostics (1 paper), Cancer Research and Treatments (1 paper), Diabetes Treatment and Management (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (925 citations), Immunology (409 citations), Pulmonary and Respiratory Medicine (432 citations), Otorhinolaryngology (30 citations) and Hepatology (52 citations). Hazel Jones has collaborated with scholars based in United Kingdom, Australia and Canada. Frequent co-authors include Jamie Honeychurch, Eleanor J. Cheadle, Amy L. Adlard, Ian J. Stratford, Grazyna Lipowska‐Bhalla, Ross Stewart, Conor McKenna, Edmund Poon, Simon J. Dovedi and Robert W. Wilkinson. Their work appears in journals such as British Journal of Cancer, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.